Pyrido[2,3-b]pyrazine-6-carboxylic acid, 95.0%, 500mg

ethyl 8-chloro-2-oxooctanoate, 97.0%, 1g

cyclohexyl 3-(piperidinomethyl)phenyl ketone, 97.0%, 1g

2-(Benzyloxy)-2-methylpropanoic acid, 97%, 100mg

2,6-Bis((R)-4-benzyl-4,5-dihydrooxazol-2-yl)pyridine, 95.0%, 250mg

2-Bromo-2-methylbutane, 95.0%, 5g

3-Phenylpiperidine>98.0%(T)1g

6-Methoxy-2-(4-methyl-1,4-diazepan-1-yl)-4-((1-methylpiperidin-4-yl)amino)quinazolin-7-ol (trihydrochloride), 98%, 50mg

6-NITRO-3-(1-BENZYL-1,2,3,6-TETRAHYDROPYRIDIN-4-YL)-1H-INDOLE, 97.0%, 250mg

4-Bromo-1-methyl-1H-pyrazole-5-carbonitrile, 97.0%, 25g

Iron (III) chloride, min. 98.5%, ultra pure, anhydrous, 250 g, glass packaging

(S)-(-)-1-Ethyl-2-pyrrolidinecarboxamide>98.0%(GC)(T)1g

1-Decene [Standard Material for GC]>99.5%(GC)5mL